SEMINAR: CARB-X - The First 6 Years

We were delighted to have Chief Scientist of CARB-X, Richard Alm, deliver an insightful seminar into the global AMR scene and the overarching mission of CARB-X in tackling AMR and improving its outcomes. CARB-X is the only global partnership that predominantly supports antibacterial research.

You can access the seminar recording through this link.

About the speaker

Richard Alm, PhD

Chief Scientist

Richard joined CARB-X following almost 20 years in large pharma infection R&D teams followed by 4 years at a small antibacterial biotech company. He has supported the progression of small molecule compounds from discovery through to late-stage clinical development. He obtained his PhD in molecular microbiology from the University of Adelaide, and prior to joining industry he had two post-doctoral positions in the AMR area, one in Australia and one in Canada.